The company I have been given to base my assignment tasks on for the ACCT11059 unit is Recce (pronounced Re-Key) Pharmaceuticals. So who are they and what do they do?
Australia's Recce Pharmaceuticals is a biotechnology business dedicated to creating an innovative class of synthetic antibiotics. The company's main product, RECCE 327, is well-known for its ability to specifically target and eradicate bacteria, including types resistant to antibiotics. With a distinct mode of action, Recce's anti-infectives aim to provide doctors with a therapeutic tool that works against a variety of germs and may be used time and time again.
A fast-acting, broad-spectrum antibiotic, RECCE® 327 is efficient against both Gram-positive and Gram-negative bacteria, including superbugs that are resistant to antibiotics. For oral usage, RECCE® 435 is a synthetic polymer antibiotic with a broad spectrum of activity. RECCE® 529 is an anti-infective synthetic polymer that targets viral indications in accordance with Recce's prior antiviral research. The following information clip was taken from Recce's website to help you better understand what they do.
To view to-date share prices for Recce Pharmaceuticals - Recce Share Price at the time of writing this blog the share price was ASX: RCE $0.435
To further explore this company go to their website https://www.recce.com.au/ I am sure you will find it very interesting as I did.
Be sure to keep updated through my blog as I continue to unwrap the What, Why and How of this company.
Comments
Post a Comment